Pharmacy, Natural & Health Sciences

Pharmacogenomics Master's Program Outcomes

Class of 2017 PGx graduates report at a 89 percent success rate after graduation.

Graduate results were updated in April 2018 (original outcomes were as of December 2017). Results are based on 100 percent knowledge rate (the percent of graduates for which the institution has reasonable and verifiable information concerning the graduates’ post-graduation career activities), for the full cohort of nine graduates. Post-graduate success is defined as employment or enrollment in a program of continuing education.


Employment Areas/Further Education
Labs 5
Health care 1
Other employment 1
Further studies 1
Seeking employment 1
Total number of graduates 9
States (Where they are now)
Indiana 3
Missouri 2
Ohio 2
Massachusetts 1
Further studies 1
Total number of graduates 9

PGx Program Mission

The Master of Science in Pharmacogenomics Program graduates individuals of ability and conviction who benefit society through the application of pharmacogenomics in precision medicine.


The Manchester University Master of Science in Pharmacogenomics Program is accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools.

Non-Discrimination in the
Admission Process
The Manchester University Pharmacogenomics Program is committed to non-discrimination in the admissions process.The University does not discriminate on the basis of national origin, ancestry, race, color, age, sex, gender identity or expression, sexual orientation, familial status, religion, disability, physical characteristics, or veteran status in admissions including its admission decisions and scholarships or loan awards.